检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]上海中医药大学附属岳阳中西医结合医院,上海200437
出 处:《时珍国医国药》2017年第5期1135-1136,共2页Lishizhen Medicine and Materia Medica Research
基 金:上海市科委科技支撑重大项目(No.13401902801)
摘 要:目的评价疏肝和胃方治疗非糜烂性胃食管反流病临床疗效。方法将60例非糜烂性胃食管反流病患者,随机分为中药组30例,西药组30例,分别予以疏肝和胃方及雷贝拉唑治疗,疗程8周,观察两组之间临床症状及临床有效率的改善情况。结果在改善临床症状及有效率方面,两组差异有统计学意义(P<0.05)。结论疏肝和胃方在改善临床症状及有效率方面优于雷贝拉唑。Objective To evaluate the clinical curative effect by Shugan Hewei Decoction on the treatment of NERD.Methods In the 60 cases of NERD 30 cases are randomly divided into Chinese medicine group,and western medicine group of 30 cases,respectively,who take Shugan Hewei Decoction and rabeprazole respectively. By the course of 8 weeks,observe clinical symptoms and clinical efficient between two groups. Results In improving clinical symptoms and efficient,the differences between the two groups have statistical significance( P 0. 05). Conclusion The efficiency of Shugan Hewei Decoction group in improving clinical symptom and efficiency is higher than rabeprazole group.
关 键 词:非糜烂性胃食管反流病 疏肝和胃方 临床疗效
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15